News

Analyzing Ameresco's Financial Performance Before Earnings

Analyzing Ameresco's Financial Performance Before Earnings

Understanding Ameresco's Financial Landscape

Ameresco Inc (NYSE: AMRC) is set to unveil its quarterly earnings report soon. As expectations build, investors are keen to assess the company's financial health and performance indicators prior to this release.

Expected Earnings Report Insights

Analysts project that Ameresco will report an earnings per share (EPS) of approximately $0.07. This figure serves as a benchmark against which the company’s performance will be measured.

Anticipated Guidance Implications

The forthcoming announcement is highly anticipated by stakeholders who hope the company will provide guidance that exceeds market expectations. Such revelations can significantly impact stock valuation moving forward.

Earnings Track Record

Last quarter, Ameresco surpassed EPS estimates by a notable margin of $0.14, resulting in a remarkable 11.78% surge in share price the following day. This upward momentum highlights the market's reactive nature to positive financial news.

Reviewing Ameresco's Performance Trends

As of the latest market close, Ameresco shares were priced at $16.92, reflecting a decrease of 40.82% over the past year. Such a downturn may cause concern among long-term investors, impacting their confidence ahead of the earnings release.

Analyst Perspectives on Ameresco

Being attuned to analyst sentiments and trends within the sector is crucial for investors. Currently, Ameresco holds a consensus rating of 'Buy' from five analysts, with an average one-year price target set at $19.4. This indicates a potential upside of around 14.66% compared to its current trading price.

Comparing Peer Performances

To provide context, we can consider insights from peers like Bowman Consulting Group, Limbach Holdings, and Tutor Perini. Each of these companies has garnered attention through favorable analyst ratings:

  • Bowman Consulting Group boasts a 'Buy' stance with a one-year target of $36.0, suggesting an impressive upside of 112.77%.
  • Limbach Holdings also enjoys a 'Buy' rating, its average target set at $148.2, indicating a massive upside potential of 775.89%.
  • Tutor Perini is similarly rated 'Buy,' with a projected target of $50.0, signaling an upside of 195.51%.

Ameresco Against Its Peers

A comparative analysis reveals that Ameresco currently ranks lower in more substantive metrics, such as revenue growth and gross profit, than its industry counterparts. However, it stands out with a relatively high Return on Equity.

Getting Acquainted with Ameresco

Ameresco primarily provides energy efficiency solutions across North America and Europe, focusing on projects designed to reduce energy costs while enhancing operational efficiency. Its diverse offerings range from solar energy systems to maintenance solutions for various institutional and commercial facilities.

Examining Ameresco's Financial Health

Market Capitalization Overview: The market capitalization of Ameresco reflects its current growth trajectory and operational scale, suggesting it hovers below the industry average, which could be reflective of its growth potential.

Revenue Growth Insights: Currently, Ameresco's 18.24% revenue growth rate indicates a robust performance within the context of recent earnings. However, when stacked against peer companies, challenges persist due to more severe downturns.

Profitability Metrics: Ameresco's net margin remains a concern, reflecting a figure of -1.56%, indicating hurdles in achieving sustainable profitability. This metric is critical for stakeholders seeking stable financial returns.

Rethinking Returns: With an ROE of -0.54%, Ameresco’s performance metrics indicate lingering challenges in capitalizing on equity, also evident in its Return on Assets (ROA) standing at -0.13%.

Debt Levels: Ameresco's debt-to-equity ratio of 1.76 suggests a heightened level of debt, raising red flags regarding potential financial strain as it navigates a competitive market landscape.

Frequently Asked Questions

What earnings are expected from Ameresco for the upcoming report?

Analysts anticipate an EPS of about $0.07 as part of Ameresco's upcoming earnings report.

What has been the recent price performance of Ameresco?

As of the latest update, Ameresco shares were trading at $16.92, reflecting a significant decline of 40.82% over the past year.

What is the consensus rating for Ameresco from analysts?

The consensus rating for Ameresco is 'Buy' with an average one-year price target of $19.4.

How does Ameresco compare to its industry peers?

Ameresco ranks low in revenue growth and gross profit among its peers but demonstrates a strong Return on Equity.

What are the key offerings of Ameresco?

Ameresco specializes in energy efficiency solutions and solar energy systems for various institutional and industrial clients.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 2

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 6

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 4

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 5

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 6

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading

Top 5 Most Recently Viewed Articles

Aligos Therapeutics Enhances Workforce with New Inducement Grants

Updated Category News Views 151

Aligos Therapeutics Implements Stock Options for New Hires Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a pioneering biopharmaceutical company committed to developing innovative therapies aimed at enhancing patient outcomes for liver and viral diseases. In a recent move, the company’s Compensation Committee has granted non-qualified stock options amounting to 26,000...

Continue Reading
Assessing Liquidity: Dassault Systèmes Partnership Insights

Updated Category News Views 208

Understanding the Recent Liquidity Contract Updates Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) recently released an update concerning its liquidity contract with Oddo BHF SCA. This contract, which commenced back in January 2015, has seen significant adjustments over the years to enhance trading efficiency and market transparency. The latest report reveals...

Continue Reading
Agroz Scrambles to Resolve Nasdaq Delisting Threat

Updated Category News Views 21

Navigating The Murky Waters of Compliance Agroz Inc., an agricultural technology firm, is engaging in a tense dance with Nasdaq, having received a stern delisting notice. When a company's stock dives below that critical $1 mark for too long, like Agroz’s has, alarm bells ring. Nasdaq isn't exactly handing out participation trophies; they're sending Agroz packing unless...

Continue Reading
Junshi Biosciences Achieves Major Breakthrough in Lung Cancer Treatment

Updated Category News Views 213

Significant Milestone for Junshi Biosciences in Cancer Treatment Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180) has made waves in the biopharmaceutical landscape by announcing that its JS001sc-002-III-NSCLC study has successfully met its primary endpoints. This Phase 3 clinical trial, which is pivotal for patients suffering from...

Continue Reading
Analyzing Ameresco's Financial Performance Before Earnings

Updated Category News Views 113

Understanding Ameresco's Financial Landscape Ameresco Inc (NYSE: AMRC) is set to unveil its quarterly earnings report soon. As expectations build, investors are keen to assess the company's financial health and performance indicators prior to this release. Expected Earnings Report Insights Analysts project that Ameresco will report an earnings per share (EPS) of...

Continue Reading